Gujarat Inject Kerala Valuation
GUJINJEC · Healthcare · Current price ₹12.63
Is Gujarat Inject Kerala undervalued?
DocStoX estimates the fair value of Gujarat Inject Kerala at ₹8 per share, versus the current market price of ₹13. That puts the stock about -38.4% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 2 independent methods: Relative P/E (₹11), Graham floor (₹2). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹2 (bear) to ₹8 (base) to ₹11 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Gujarat Inject Kerala trades at a P/E of 60.1x and a P/B of 15.7x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Gujarat Inject Kerala
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.